Skip to main content

Mood Stabilizers

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology
  • 206 Accesses

Synonyms

Long-term treatments for bipolar disorder

Definition

Mood stabilizers are pragmatically defined by their clinical efficacy in bipolar disorder. Bipolar disorder is a complex condition, as it is expressed as episodic periods of contrasting mood disturbance – mania and depression – and its long-term or maintenance treatment must prevent new episodes of both. Any medicine that achieves this can be said to be a mood stabilizer.

Pharmacological Properties

History

The first mood stabilizer was lithium. It was discovered over 60 years ago by guided serendipity. Lithium salts of urea were found by the Australian doctor John Cade to be sedative in animals. He had reasoned that urea itself was an active component, but realized that, in fact, lithium was unexpectedly tranquilizing. Immediate trials in patients with mania suggested acute efficacy, and subsequent experience showed that lithium could markedly modify the course of bipolar disorder (then called manic depression) in the long...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Bauer MS, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry. 2004;161(1):3–18.

    Article  PubMed  Google Scholar 

  • Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomised controlled trials. Am J Psychiatry. 2004;161:217–22.

    Article  PubMed  Google Scholar 

  • Goodwin GM. The recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry. 1994;164:149–52.

    Article  CAS  PubMed  Google Scholar 

  • Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23:346–88.

    Article  CAS  PubMed  Google Scholar 

  • Harwood AJ, Agam G. Search for a common mechanism of mood stabilisers. Biochem Pharmacol. 2003;66:179–89.

    Article  CAS  PubMed  Google Scholar 

  • Harwood AJ, Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity CNS Neurol Disord Drug Targets. 2011;10:333–339.

    Article  Google Scholar 

  • Malhi GS, Berk M, Bourin M, Ivanovski B, Dodd S, Lagopoulos J, et al. Atypical mood stabilisers: a ‘typical’ role for atypical antipsychotics. Acta Psychtr Scand. 2005;111 Suppl 426:29–38.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guy M. Goodwin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Goodwin, G.M. (2014). Mood Stabilizers. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_259-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_259-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics